Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Psychotropic medications can cause skin problems but also treat some skin conditions.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Adults with trichotillomania do not have different pain sensitivity to cold pressor pain compared to healthy individuals.

Sex steroids produced in the hippocampus are crucial for brain functions like memory and learning in rodents.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Most people worried about abnormal hair loss actually have psychological issues like depression or anxiety.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Zinc levels in body fluids can help diagnose zinc deficiency in lambs, with fecal zinc as an early indicator.

Early NAS level changes affect alcohol consumption vulnerability.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

PRP can improve hair growth in people with hair loss, but more research is needed.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.